2025 PARTNERS
Expertise Partner - Satorius
Sartorius is a leading global partner of the biopharmaceutical industry dedicated to enabling cell and gene therapy developers to manufacture and commercialize their advanced therapy medicinal products (ATMPs). Over the last decade the company has expanded its legacy portfolio of single-use bioprocessing solutions through the acquisition of complementary advanced therapy consumables, services, and technologies—from plasmid engineering and manufacturing to cell culture media, reagents and monolithic chromatography. Sartorius’ advanced therapy solutions are designed to overcome current production challenges by enhancing productivity, improving process economics, and supporting safe and regulatory compliant manufacturing. Sartorius products are currently used in approved cell and gene therapies and actively support clinical pipelines worldwide. The company’s continued investment in innovative solutions demonstrates their commitment to advancing the field and making access to these life-saving treatments a reality.
Exhibition Partner - BioIVT
BioIVT is a global leader in delivering high-quality biological specimens and research services, from human and animal tissues to cell and gene therapy starting materials, empowering precision medicine and CGT innovation. With an unmatched portfolio that includes control and diseasestate samples, ADME‑Tox products, PBMCs, leukopaks, and more, they enable researchers to accelerate therapeutic discovery and development. Leveraging a worldwide network of donor centers and clinical sites, BioIVT ensures continuity, diversity, and compliance with RUO and GMP standards, supporting clients from early-stage research through clinical translation.
Innovation Partner - ProDeMaCon Consulting
ProDeMaCon™ LLC (San Francisco, CA) is a boutique business consulting firm for the Pharma and Biotech sectors. We assist Pharma and Biotech clients in developing comprehensive pharmaceutical and regulatory strategies.
Over the last decade, we have collaborated with numerous cell & gene therapy companies and CDMOs to support their raw material and supplier management efforts - compliantly and phase-appropriately. We firmly believe that a solid material/supplier strategy is essential for success and sustainable business growth.
